Nucleic acid-encapsulating polymer micelle complex and method for producing same
| 外国特許コード | F170009176 |
|---|---|
| 整理番号 | K10503WO |
| 掲載日 | 2017年9月12日 |
| 出願国 | 欧州特許庁（ＥＰＯ） |
| 出願番号 | 14835122 |
| 公報番号 | 3031447 |
| 公報番号 | 3031447 |
| 出願日 | 平成26年8月5日(2014.8.5) |
| 公報発行日 | 平成28年6月15日(2016.6.15) |
| 公報発行日 | 令和元年12月25日(2019.12.25) |
| 国際出願番号 | JP2014070567 |
| 国際公開番号 | WO2015020026 |
| 国際出願日 | 平成26年8月5日(2014.8.5) |
| 国際公開日 | 平成27年2月12日(2015.2.12) |
| 優先権データ |
|
| 発明の名称 （英語） | Nucleic acid-encapsulating polymer micelle complex and method for producing same |
| 発明の概要（英語） | A nucleic acid-encapsulating polymer micelle complex is formed of a block copolymer containing an uncharged hydrophilic polymer chain block and a cationic polymer chain block; and two single-stranded DNA molecules having mutually complementary base sequences of 1000 or more bases in length, double-stranded DNA of 1000 or more base pairs in length in which at least a part of a double helix structure is dissociated and forms a single-stranded structure, or one single-stranded DNA molecule of 1000 or more bases in length. |
| 従来技術、競合技術の概要（英語） |
Background Art As a next-generation treatment, gene therapy for treating diseases by controlling gene expression has been greatly anticipated. The biggest problem with gene therapy is that introduction efficiency at the time when genes are introduced into target cells or tissues is insufficient. Particularly, in order to realize gene therapy through systemic administration, it is necessary that genes be stably circulated in the blood and accumulated on target tissues and that gene expression be effectively performed after genes have entered target tissues. Here, in order to solve these problems, development of gene carriers having better introduction efficiency to target cells or the like, and gene expression efficiency in target cells has been actively promoted. For example, it is known that a polymer in which a primary structure is precisely controlled is spontaneously organized and may form a higher-order structure such as a micelle or a vesicle and use of a structure obtained by a polymer being self-organized in such a manner has been previously examined in various fields including drug delivery systems and material science. For example, PTL 1 discloses an electrostatic binding type polymer micelle drug carrier formed of a block copolymer including an uncharged segment (uncharged polymer chain block) and a charged segment (charged polymer chain block) and capable of encapsulating a drug having an opposite charge to that of the charged segment, in a core portion. When a cationic segment is used as the charged segment, it is possible to encapsulate DNA in the core portion. Furthermore, research performed for stabilization of a polymer micelle in various manners has been reported. For example, in regard to an electrostatic binding type polymer micelle drug carrier, PTL 2 discloses an electrostatic binding type polymer micelle drug carrier stabilized by crosslinking block copolymers through a crosslinking agent. In addition, PTL 3 discloses a block copolymer formed by containing an uncharged hydrophilic polymer chain block and a cationic polyamino acid chain block in which a hydrophobic group is introduced into a part of the side chain thereof. By virtue of a hydrophobic group introduced into the side chain of the block copolymer, interfacial energy is increased, thereby the cohesive force in a micelle becomes higher and the core becomes smaller, and thus, the polymer micelle is stabilized. Citation List Patent Literature [PTL 1] Japanese Unexamined Patent Application, First Publication No. H8-188541 [PTL 2] PCT International Publication No. WO2004/105799 [PTL 3] PCT International Publication No. WO2009/113645 [PTL 4] US patent application No. US 2010/0278927 |
| 特許請求の範囲（英語） |
[claim1] 1. A nucleic acid-encapsulating polymer micelle complex formed of a block copolymer containing an uncharged hydrophilic polymer chain block and a cationic polymer chain block; and two single-stranded DNAs having mutually complementary base sequences of 1000 or more bases in length, double-stranded DNA of 1000 or more base pairs in length in which at least a part of a double helix structure is dissociated and forms a single-stranded structure, or one single-stranded DNA of 1000 or more bases in length. [claim2] 2. The nucleic acid-encapsulating polymer micelle complex according to Claim 1, formed of a block copolymer containing an uncharged hydrophilic chain block and a cationic polymer chain block; and two single-stranded DNAs having mutually complementary base sequences of 1000 or more bases in length or double-stranded DNA of 1000 or more base pairs in length in which at least a part of a double helix structure is dissociated and forms a single-stranded structure. [claim3] 3. The nucleic acid-encapsulating polymer micelle complex according to Claim 1 or 2, wherein the single-stranded DNA is 2000 or more bases in length, and the double-stranded DNA is 2000 or more base pairs in length. [claim4] 4. The nucleic acid-encapsulating polymer micelle complex according to any one of Claims 1 to 3, wherein the average particle diameter thereof in an aqueous medium measured according to a dynamic light scattering method is 100 nm or less. [claim5] 5. The nucleic acid-encapsulating polymer micelle complex according to any one of Claims 1 to 4, wherein the DNA and the cationic polymer chain block bonded to the DNA due to an electrostatic interaction form a core portion, and the uncharged hydrophilic polymer chain block forms a shell portion. [claim6] 6. The nucleic acid-encapsulating polymer micelle complex according to Claim 5, wherein the average particle diameter of the core portion is 50 nm or less. [claim7] 7. The nucleic acid-encapsulating polymer micelle complex according to any one of Claims 1 to 6, wherein the complex is spherical. [claim8] 8. The nucleic acid-encapsulating polymer micelle complex according to any one of Claims 1 to 7, wherein the single-stranded DNA or the double-stranded DNA is linear. [claim9] 9. The nucleic acid-encapsulating polymer micelle complex according to any one of Claims 1 to 8, wherein at least a part of the block copolymer is mutually cross-linked. [claim10] 10. The nucleic acid-encapsulating polymer micelle complex according to any one of Claims 1 to 9, wherein a hydrophobic group is covalently bonded to a main chain or a side chain of the cationic polymer chain block. [claim11] 11. The nucleic acid-encapsulating polymer micelle complex according to any one of Claims 1 to 10, wherein the cationic polymer chain block has an ethylamine structure or a propylamine structure in the side chain thereof. [claim12] 12. A method for producing a nucleic acid-encapsulating polymer micelle complex which accommodates DNA, the method comprising: a process of mixing a block copolymer containing an uncharged hydrophilic polymer chain block and a cationic polymer chain block with double-stranded DNA of 1000 or more base pairs in a state in which at least a part of a double helix structure is dissociated, in an aqueous medium. [claim13] 13. The method for producing a nucleic acid-encapsulating polymer micelle complex according to Claim 12, wherein the double-stranded DNA is 2000 or more base pairs in length. [claim14] 14. The method for producing a nucleic acid-encapsulating polymer micelle complex according to Claim 12 or 13, wherein the double-stranded DNA is linear. [claim15] 15. The method for producing a nucleic acid-encapsulating polymer micelle complex according to any one of Claims 12 to 14, wherein the double-stranded DNA has been denatured at 60°C or higher. |
|
|
|
|
| 国際特許分類(IPC) |
|
| 指定国 | Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
| 参考情報 （研究プロジェクト等） | PRESTO Molecular technology and creation of new functions AREA |
日本語項目の表示
| 発明の名称 | 核酸内包高分子ミセル複合体及びその製造方法 |
|---|
※
ライセンスをご希望の方、特許の内容に興味を持たれた方は、問合せボタンを押してください。
『 Nucleic acid-encapsulating polymer micelle complex and method for producing same 』に関するお問合せ
- 国立研究開発法人科学技術振興機構（ＪＳＴ） 知的財産マネジメント推進部
- URL: http://www.jst.go.jp/chizai/
-
E-mail:
- Address: 〒102-8666 東京都千代田区四番町5-3
- TEL: 03-5214-8293
- FAX: 03-5214-8476
※ 同じキーワードでJ-STORE内を検索することが出来ます。→ J-STORE内を検索
